Speciality: Neurology
Description:
A warm welcome to all the medical professionals in this interesting session on Clinical manifestations and diagnosis of Neurocysticercosis.
Neurocysticercosis is a parasitic infection of the central nervous system caused by the larval stage of the pork tapeworm, Taenia sodium. The clinical manifestations vary widely depending on the number, size, and location of cysts in the brain, as well as the host's immune response. Common symptoms include seizures, which are the most frequent clinical presentation, headaches, and focal neurological deficits. Other manifestations can include hydrocephalus, meningitis, cognitive decline, and psychiatric disturbances.
Diagnosis of neurocysticercosis involves a combination of clinical evaluation, neuroimaging, and serological tests. Neuroimaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) are crucial, often revealing characteristic cystic lesions with or without scolex, calcifications, and signs of inflammation. Serological tests, including enzyme-linked immunosorbent assay (ELISA) and enzyme-linked immuno electrotransfer blot (EITB), help detect specific antibodies or antigens and support the diagnosis. Lumbar puncture and cerebrospinal fluid analysis may be used in cases of suspected meningitis or intracranial hypertension. Early and accurate diagnosis is essential for effective management and improving patient outcomes.
Therefore, get an overall knowledge of clinical manifestations and diagnosis of Neurocysticercosis.
See More Webinars @ Hidoc Webinars
1.
A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.
2.
Study: One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment
3.
Racial differences seen in epigenetic age acceleration in childhood cancer survivors
4.
ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancer
5.
Taking the "Boob Bus"; Reluctance to Grant Prior Authorization; Alcohol's Carcinogenic Potential?
1.
Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence
2.
The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025
3.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
4.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
5.
How to Prevent Tumor Lysis Syndrome in Cancer Patients
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
2.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
3.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
5.
Navigating the Complexities of Ph Negative ALL - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation